YOU ARE ENTERING HCP CONTENT ONLY

Please note you are entering now content intended only for Healthcare Professionals.

Are you a HCP?

YES I AM A HCP NO I AM NOT A HCP
placeUnited Kingdom
Contact & Support
Medtronic / Clinical Solutions / Miscarriage Management

Miscarriage management

To find a better way to manage miscarriage, we need to believe in better care.

Contact us

Believe in better outcomes.

It's time for a better way for managing miscarriages. One that’s patient first. One that lets you see what you’re treating so you can protect and preserve the uterus.1,2

Find out more reasons why physicians like you are opting for visually guided hysteroscopy over blind D&C to treat patients after early pregnancy loss.

Learn more

What physicians are saying about hysteroscopy

Aaron Styer, MD
Using the TruClear™ system to remove retained products of conception (RPOC) (03:11)

Fit for the future − for patients and your practice

Managing miscarriages with hysteroscopy lets you see-and-treat RPOC. It’s a treatment approach that can offer everyone peace of mind. 

What to expect with the TruClear™ hysteroscopic tissue removal system

of patients achieved complete removal of RPOC3

faster operative time versus other hysteroscopic resection approaches such as loop resection4

less risk of post-operative adhesion formation in patients treated with hysteroscopy (13%) versus D&C (30%)1

to test for chromosome abnormalities
(where indicated)5,6

Gain a greater vision for miscarriage management.

See the TruClear™ system in action.

When D&C is used to evacuate RPOC, 30% of cases result in intrauterine adhesions versus 13% with hysteroscopic resection.1 Explore our global value dossier to see why visually guided hysteroscopy should be the clear choice for treating RPOC in your practice.

See full story

Charles E. Miller, MD
Operative hysteroscopy for retained products of conception — using the TruClear™ system (02:13)

Ursula Catena, M.D.
Retained Product of Conception (RPOC) with TruClear™ Elite Mini with Ursula Catena, M.D. Ph.D CLASS Hysteroscopy Center Fondazione Policlinico Universitario A. Gemeli IRCCS Rome, Italy (02:20)

Why wait?

Compared with expectant, medical, and surgical intervention such as D&C, hysteroscopy may minimize the need for further intervention after miscarriage1,5 — and help preserve endometrial lining.3

Learn why we believe treatment with direct visualization3 after early pregnancy loss should be the norm. 

Explore the possibilities

Miscarriage management mHTR versus blind D&C podcast episode (38:14)

Adverse effects for operative hysteroscopy include but not limited to fluid overload due to intravasation and uterine perforation. Please refer to instructions for use (IFU) for complete contraindication and risk information. Residual risks to the patients may include but are not limited to exposure to body fluids, uterine perforation, fetal distress, metastasis (cancer), peritonitis, abscess, and air embolism. 

  1. Hooker A, Aydin H, Brölmann H, Huirne J. Long-term complications and reproductive outcome after the management of retained products of conception: a systematic review. Fertil Steril. 2016;105(1):156–164.
  2. Hooker AB, Thurkow A. Asherman’s syndrome after removal of placenta remnants: a serious clinical problem. Gynecol Surg. 2011;(8):449–453.
  3. Hamerlynck TW, Blikkendaal MD, Schoot BC, Hanstede MM, Jansen FW. An alternative approach for removal of placental remnants: hysteroscopic morcellation. J Minim Invasive Gynecol. 2013;20(6):796–802. doi:10.1016/j.jmig.2013.04.024
  4. Hamerlynck TW, van Vliet HA, Beerens AS, Weyers S, Schoot BC. Hysteroscopic morcellation versus loop resection for removal of placental remnants: a randomized trial. J Minim Invasive Gynecol. 2016;23(7):1172–1180.
  5. Weinberg S, Pansky M, Burshtein I, Beller U, Goldstein H, Barel O. A pilot study of guided conservative hysteroscopic evacuation of early miscarriage. J Minim Invasive Gynecol. 2021; 28(11):1860–1867.
  6. Young S, Miller CE. Hysteroscopic resection for management of early pregnancy loss: a case report and literature review. F S Rep. 2022;3(2):163–167. Published 2022 Mar 10. doi:10.1016/j.xfre.2022.03.002.